TY  - CHAP
M1  - Book, Section
TI  - Fever and Infection in the Immunocompromised Patient
A1  - Dvorak, Christopher C.
A1  - Auletta, Jeffery J.
A2  - Kline, Mark W.
PY  - 2018
T2  - Rudolph's Pediatrics, 23e
AB  - A  key  element  in  the  effective  care  of  immunocompromised  patients  with  fever  is  hypervigilance.  Not  only  are  these  patients  at  increased  risk  for  a  diverse  range  of  microorganisms,  but  also  infections  caused  by  these  organisms  can  present  in  subtle  or  atypical  ways  and  often  progress  to  difficult-to-treat  chronic  disease  states  or  rapid  clinical  decompensation.  Therefore,  empiric  anti-infective  therapy  is  justified  for  new-onset  fever  in  immunocompromised  patients  while  a  thorough  investigation  into  the  source  of  fever  is  performed.  Because  antimicrobial  therapies  often  have  adverse  side  effects,  an  accurate  evaluation  to  guide  definitive  antimicrobial  therapy  becomes  crucial.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/20
UR  - accesspediatrics.mhmedical.com/content.aspx?aid=1182933719
ER  -